Application of HPLC and HPTLC for the Simultaneous Determination of Cefixime Trihydrate and Ambroxol Hydrochloride in Pharmaceutical Dosage Form
 
More details
Hide details
1
Department of Pharmaceutical chemistry, MGV’S College of Pharmacy, Panchvati, Nashik-03, India
2
Sanjivani College of Pharmaceutical Education and Research, Kopargaon, Dist: Ahmednagar, (M. S.), 423603, India
CORRESPONDING AUTHOR
Veena S. Kasture   

Sanjivani College of Pharmaceutical Education and Research, Kopargaon, Dist: Ahmednagar, (M. S.), 423603, India
Publish date: 2017-10-08
 
Eurasian J Anal Chem 2010;5(3):227–238
KEYWORDS
ABSTRACT
Two sensitive and reproducible methods are described for the quantitative determination for the simultaneous estimation of cefixime trihydrate and ambroxol hydrochloride. The first method was based on HPTLC followed by densitometric measurements of their spots at 254 nm. The separation was on HPTLC aluminium sheets of silica gel 60 F254 using acetonitrile: methanol: triethylamine (8.2:1:0.8, v/v/v) as mobile phase. The linear regression analysis was used for the regression line in the range of 200–1000 ng spot-1 for cefixime and ambroxol, respectively. This system was found to give compact spots for cefixime and ambroxol, after development. The second method was based on HPLC separation of the two drugs on the column [C18 (5µ, 25 cm×4.6 mm, i.d.)] at ambient temperature using a mobile phase consisting of acetonitrile: methanol (50:50, v/v). Quantitation was achieved with UV detection at 254 nm based on peak area with linear calibration curves at concentration ranges 4–18 and 4–28μg ml-1 for cefixime and ambroxol, respectively. Both methods have been successively applied to pharmaceutical formulation. No chromatographic interference from the tablet excipients was found. Both methods were validated in terms of precision, robustness, recovery and limits of detection and quantitation.
 
REFERENCES (31)
1.
British Pharmacopoeia (2003) Her Majesty’s Stationery Office, London, vol. I p 104, 371.
 
2.
The Merck Index (2006) An Encyclopedia of Chemicals, Drugs and Biologicals 14th Edition, Merck, USA, p 386, 1974.
 
3.
Sweetman S (2002) Martindale: The Complete Drug Reference 33rd Edition, Pharmaceutical Press, p 166, 1703.
 
4.
United States Pharmacopeia, The National Formulary, (USP/NF) (2004) United States Pharmacopeial Convention, Rockville, MD, p 359.
 
5.
Brunton L, Lazo J, Parker K (2005) Goodman & Gilman's The Pharmacological Basis of Therapeutics, Eleventh Edition McGraw Hill New York p.1807.
 
6.
Xiaoyan F M, Dafang Y Z (2005) Sensitive liquid chromatography–tandem mass spectrometry method for the determination of cefixime in human plasma: Application to a pharmacokinetic study. Journal of Chromatography B, 819:277.
 
7.
Jovanovic S E, Agbaba D, Stakic D Z, Vladimirov S (1998) HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms. Journal of Pharmaceutical and Biomedical Analysis 18:893.
 
8.
Al-Momani I F (2001) Spectrophotometric determination of selected cephalosporins in drug formulations using flow injection analysis. J Pharma Biomed Anal 25:751-757.
 
9.
Quintiliani R (1996) Cefixime: A Pharmacoeconomic Perspective. Current Therapeutic Research 57:12.
 
10.
Fattah A, El-Walily M, Gazy A A, Belal S F, Khamis E F (2000) Quantitative determination of some thiazole cephalosporins through complexation with palladium (II) chloride. J Pharm Biomed Anal. 22:385.
 
11.
Hang T, Zhang M, Song M, Shen J, Zhang Y (2007) Simultaneous determination and pharmacokinetic study of roxithromycin and ambroxol hydrochloride in human plasma by LC-MS/MS. Clinica Chimica Acta 382:20.
 
12.
Heinanen M, Barbas C (2001) Validation of an HPLC method for the quantification of ambroxol hydrochloride and benzoic acid in a syrup as Pharmaceutical form stress test for stability evaluation. Journal of Pharmaceutical and Biomedical Analysis 24:1005.
 
13.
Hadad G M, El-Gindy A, Mahmoud M M (2008) HPLC and chemometrics-assisted UV-spectroscopy methods for the simultaneous determination of ambroxol and doxycycline in capsule. Spectrochimica Acta Part A Molecular and biomolecular spectroscopy; 70:655.
 
14.
Kim H, Yoo J Y, Han S B, Lee H J (2003) Determination of ambroxol in human plasma using LC-MS/ MS. Journal of Pharmaceutical and Biomedical Analysis 32:209.
 
15.
Meiling Q, Wang P, Cong R, Yang J (2004) Simultaneous determination of roxithromycin and ambroxol hydrochloride in a new tablet formulation by liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 35:1287.
 
16.
Dincer Z, Basan H, Goger N G (2003) Quantitative determination of ambroxol in tablets by derivative UV spectrophotometric method and HPLC. Journal of Pharmaceutical and Biomedical Analysis 31: 867.
 
17.
Satınsky D, Lucia M L, Santos D, Sklenarov H, Solich P, Conceic M¸ Montenegro B S M, Araujo A N (2005) Sequential injection chromatographic determination of ambroxol hydrochloride and doxycycline in pharmaceutical preparations. Talanta 68:214.
 
18.
ICH/CPMP guidelines Q2A (1994) Text on Validation of Analytical Procedures.
 
19.
ICH/CPMP Guidelines Q2B (1996) Validation of Analytical ProceduresMethodology.
 
20.
The United State Pharmacopoeia (USP NF) (2004) The Official Compendia of Standards, Asian Edition, p. 2622.
 
21.
Chan C C, Lee Y C, Lam H, Zhang X M (2004) Analytical Method Validation and Instrument Performance Verification, John Wiley and Sons, INC., p 11.
 
22.
Sethi P D (1996) HPTLC: Quantitative Analysis of Pharmaceutical Formulation, CBS Publications, New Delhi, p 162-65.
 
23.
Sethi P D (1996) HPLC: Quantitative Analysis of Pharmaceutical Formulation, CBS Publications, New Delhi, p 1-28.
 
24.
Heftman E (2004) Chromatography, Journal of Chromatography Library 69A, 6th (ed.), Elsevier, Amsterdam, p 254-60.
 
25.
Christian G D (2004) Analytical Chemistry, 6th Edn, Wiley International; p. 604-620.
 
26.
Mendham J, Denney R C, Barnes J D, Thomas M J K (2004) Vogel’s Textbook of Qualitative Chemical Analysis, 6th Edn, Pearson Publications; p. 268.
 
27.
Skoog D A, Holler F J, Timothy A, Nieman N W (1985) Principle of Instrumental Analysis, 3rd Edn., Stanford University, Saunders College Publications, London, p. 1- 4.
 
28.
Sethi P D (1997) Quantitative Analysis of Drugs in Pharmaceutical Formulations, 3rd Edn., CBS Publishers and Distributors, New Delhi, p. 50-64.
 
29.
Svelha G. (1986) Wilson and Wislson’s Comprehensive Analytical Chemistry, Analytical Visible and UV Spectroscopy, p.339-358.
 
30.
Mellon M G (1952) Analytical Absorption Spectroscopy, Absorptiometry and Colorimetry, John Wiley and sons, New York; p. 20.
 
31.
Skoog D A, Holler F J, Nieman T A (2005) Principles of Instrumental Analysis, 5th (ed.), Thomson Brook/ cole, p 761-65.
 
eISSN:1306-3057